Tablets could change that, but only if they are introduced responsibly, with the right education, support and expectations in place. Jason Murphy, Head of Pharmacy at Chemist4U The needle barrier holding people back GLP-1 injections have revolutionised weight loss, allowing those facing obesity and other weight-related conditions to take a meaningful step towards a healthier life
The pitfalls of screening and self-reporting Having a history of an eating disorder doesnt preclude you from using a GLP-1, but experts stress that practitioners should be screening all patients for the potential for recurrence or misuse and closely monitoring them to flag any worsening eating disorder symptoms
Compounded versions are not interchangeable with branded products because they have different levels of clinical validation and predictability
Gastrointestinal effects (nausea, diarrhea) are common initially
In humans, 75% of carnitine is obtained from the diet [2]
Wegovy (semaglutide) is a synthetic version of a naturally occurring hormone called glucagon-like peptide-1 (GLP-1)